Allogene Therapeutics Inc
NASDAQ:ALLO

Watchlist Manager
Allogene Therapeutics Inc Logo
Allogene Therapeutics Inc
NASDAQ:ALLO
Watchlist
Price: 2.54 USD -6.62% Market Closed
Market Cap: 531.1m USD
Have any thoughts about
Allogene Therapeutics Inc?
Write Note

P/OCF
Price to OCF

-2.4
Current
-3.5
Median
23.4
Industry
Higher than median
Lower than industry value

Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.

P/OCF
-2.4
=
Market Cap
532.1m USD
/
Operating Cash Flow
-217.3m USD
All Countries
Close
 
US
Allogene Therapeutics Inc
NASDAQ:ALLO
Average P/OCF: 20.9
Negative Multiple: -2.4
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -236 050.3
US
Abbvie Inc
NYSE:ABBV
18.3
US
Amgen Inc
NASDAQ:AMGN
22
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -134.3
US
Gilead Sciences Inc
NASDAQ:GILD
11.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -476.6
AU
CSL Ltd
ASX:CSL
32.2
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
20.6
US
S
Seagen Inc
F:SGT
Negative Multiple: -76.9
NL
argenx SE
XBRU:ARGX
Negative Multiple: -138.6

P/OCF Forward Multiples

Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A

See Also

Discover More